Newswire (Published: Monday, August 12, 2019, Received: Monday, August 12, 2019, 6:18:56 PM CDT)

Word Count: 580

2019 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news reporting from Boston, United States, by NewsRx journalists, research stated, “We investigated the quality of care at minority serving hospitals compared to other institutions for men with localized intermediate and high risk prostate cancer. Using the National Cancer Database we identified 536,539 men 40 years old or older who presented with localized intermediate and high risk prostate cancer in the United States between 2004 and 2015.”

Funders for this research include Brigham Research Institute, Bruce A. Beal and Robert L. Beal Surgical Fellowship, American Society of Clinical Oncology Conquer Cancer Foundation, Defense Health Agency Health Services, Prostate Cancer Foundation, Vattikuti Urology Institute, German Research Foundation.

The news correspondents obtained a quote from the research from Brigham and Women’s Hospital, “Institutions were ranked according to the proportion of black and Hispanic patients treated at a given institution, and the top decile institutions were defined as minority serving hospitals. We used multivariable analyses to characterize the association between minority serving hospitals and 3 end points, including receipt of definitive treatment, time to definitive treatment and receipt of androgen deprivation therapy in young (65 years or younger) and healthy (no comorbidity) men treated with external beam radiation therapy. A total of 162 and 1,168 hospitals were defined as minority and nonminority serving hospitals, respectively. On multivariable analyses treatment at minority serving hospitals was associated with decreased odds of receiving definitive treatment (adjusted OR 0.73, 95% CI 0.62-0.85, p<0.001). Adjusted mean SE time to treatment was significantly longer at minority serving hospitals compared to nonminority serving hospitals (4.9 +/- 2.2 days, p = 0.024). Among young and healthy men there was no association between treatment at a minority serving hospital and receipt of androgen deprivation therapy in conjunction with external beam radiation (AOR 0.90, 95% CI 0.75-1.09, p = 0.291). Treatment at a minority serving hospital was associated with lower odds of receiving definitive therapy and longer time to definitive therapy for localized intermediate and high risk prostate cancer despite adjustment for race.”

According to the news reporters, the research concluded: “This suggests that some racial disparities in prostate cancer may be explained by the sites at which racial and/or ethnic minorities receive care.”

For more information on this research see: Quality of Care In the Treatment of Localized Intermediate and High Risk Prostate Cancer At Minority Serving Hospitals. The Journal of Urology, 2019;201(4):735-741. The Journal of Urology can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA.

Our news journalists report that additional information may be obtained by contacting Q.D. Trinh, Brigham and Women’s Hospital, Division of Urological Surgery, 45 Francis St, Asb 2-3, Boston, MA 02115, United States. Additional authors for this research include M.J. Krimphove, S.A. Fletcher, A.P. Cole, S. Berg, M. Sun, A.S. Kibel, S.R. Lipsitz, J.S. Weissman, B.A. Mahal, P.L. Nguyen, T.K. Choueiri and L.A. Kluth.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.juro.2018.10.024. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Companies

Lippincott Williams & Wilkins
Wolters Kluwer N.V.
Wolters Kluwer N.V.
Wolters Kluwer N.V.

Industries

Healthcare
      Healthcare Facilities
            Hospitals

Places

North America
United States
Americas
Massachusetts
Pennsylvania
Boston
Philadelphia

Subjects

Science and Technology
      Scientific Research
            Medical Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Health Sciences
            Medical Research
      Medical Specialties and Practices
            Urology